Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy
Clinical trial NCT04778579 · UNKNOWN
Trial details
- NCT number
- NCT04778579
- Sponsor
- Sara V. Latorre
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-11
- Primary completion
- 2024-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.